THRD - Third Harmonic Bio Inc. Qarzning balans kapitallashuviga nisbati

Third Harmonic Bio Inc. (THRD) grafik logotipi

Og'iz orqali qabul qilinadigan urtikariya dori vositasining oraliq sinov ma'lumotlari kutilmoqda va tadqiqot va ishlanmalar (R&D) xarajatlari allaqachon narxga kiritilgan. Dermatit terapiyalariga bo'lgan yuqori talab Third Harmonic Bio (THRD) kompaniyasiga narxlarni belgilash imkoniyatini beradi. Tarixiy qarzning kitob qiymatiga nisbati dinamikasi ushbu koeffitsient 0.01 darajasida ekanligini ko'rsatmoqda. Allergiyalarga qarshi kurashish uchun noyob ilmiy asoslar atrofida nufuzli immunologlar jamoasi shakllantirilmoqda.

THRD (Third Harmonic Bio Inc) Qarzning balans qiymatiga nisbati tarixi 28.04.2023dan 16.08.2025gacha
Third Harmonic Bio Inc. asosiy tovari

Third Harmonic Bio kompaniyasining bitta inhibitorni ishlab chiqishga qaratilgan yagona mahsulotli strategiyasi uning kapital tuzilmasining klinik sinovlar muvaffaqiyatiga yuqori darajada bog'liqligini yuzaga keltiradi. Ushbu xavf umumiy majburiyatlarning sof aktivlar qiymatiga nisbati ko'rsatkichida aks etgan. Ushbu metrika biznesning o'z balansidagi kapitalga nisbatan leveraj darajasini o'lchaydi. Balansdagi kapital tuzilmasi xavf ko'rsatkichining real vaqt rejimida monitoring qilinishi kompaniyaning sohaga xos ikkilik natijalarga (binary outcomes) chidamliligini baholash imkonini beradi. Bu yerda past leveraj yashab qolishni kafolatlaydi, ammo kengayish sur'atlarini cheklaydi.

Third Harmonic Bio kimlar bilan raqobatlashadi

Balans kapitallashuviga qarzlar ARGX (argenx SE)|biontech.de - Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati ABIVAX (ABVX)|ADMA: Qarzning sof aktivlarga nisbati|PTGX (Protagonist Therapeutics Inc) - Qarzning balans kapitallashuviga nisbati|Immunovant Therapeutics (IMVT) - Qarzning balans qiymatiga nisbati|KNSA (Kiniksa Pharmaceuticals) - Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar grifols.com (GRFS)|Adaptive Biotechnologies Corporation (ADPT) - Qarzning balans qiymatiga nisbati|Qarzning sof aktivlarga nisbati Celldex Therapeutics Inc (CLDX)|Balans kapitallashuviga qarzlar AUPH|BioCryst Corp - Sof aktivlarga qarzlar|VERA: Qarzning balans kapitallashuviga nisbati|DNTH: Qarzning balans qiymatiga nisbati|PHVS (Pharvaris) - Qarzning balans kapitallashuviga nisbati|Qarzning balans qiymatiga nisbati AbCellera Bio|TRML (Tourmaline Corp) - Qarzning balans qiymatiga nisbati|Balans kapitallashuviga qarzlar PGEN|Qarzning balans kapitallashuviga nisbati Pharming Group N.V. PHAR|Qarzning balans qiymatiga nisbati nektar.com (NKTR)|UPB: Balans kapitallashuviga qarzlar|ZBIO - Balans qiymatiga qarzlar|Qarzning balans qiymatiga nisbati Immunome Corp IMNM|GOSS - Qarzning balans kapitaliga nisbati|Balans kapitallashuviga qarzlar KalVista Pharmaceuticals KALV|septerna.com (SEPN) - Qarzning sof aktivlarga nisbati|PVLA: Balans kapitallashuviga qarzlar|Sof aktivlarga qarzlar SVRA|Rigel Pharmaceuticals Inc (RIGL) - Qarzning balans kapitallashuviga nisbati|Qarzning sof aktivlarga nisbati AnaptysBio Inc. (ANAB)|ATXS - Balans kapitallashuviga qarzlar|ENGN - Qarzning balans qiymatiga nisbati|Qarzning balans qiymatiga nisbati RAPT Therapeutics, Inc. (RAPT)|JBIO - Qarzning sof aktivlarga nisbati|Balans kapitallashuviga qarzlar Aclaris ACRS|Kyverna Therapeutics, Inc (KYTX) - Qarzning sof aktivlarga nisbati|TLSA (Tiziana Life Sciences) - Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar CABA|Ventyx Biosciences, Inc. (VTYX) - Qarzning balans kapitallashuviga nisbati|Qarzning sof aktivlarga nisbati THTX (Theratechnologies, Inc.)|Avalo Therapeutics Inc. - Qarzning balans kapitallashuviga nisbati|Eledon Pharmaceuticals, Inc - Qarzning balans qiymatiga nisbati|AGEN (Agenus) - Qarzning balans kapitallashuviga nisbati|CLYM: Balans qiymatiga qarzlar|Qarzning balans kapitallashuviga nisbati Zura Bio Limited|aTyr Pharma Inc (ATYR) - Qarzning balans qiymatiga nisbati|ADAG: Balans kapitallashuviga qarzlar|Sof aktivlarga qarzlar Ikena Oncology, Inc.|Balans kapitallashuviga qarzlar STTK (Shattuck Labs, Inc.)|Qarzning balans qiymatiga nisbati equilliumbio.com EQ|Qarzning balans qiymatiga nisbati Connect Biopharma Holdings Limited|Qarzning sof aktivlarga nisbati Immunic Therapeutics IMUX|ATRA - Balans kapitallashuviga qarzlar|IFRX - Qarzning balans kapitallashuviga nisbati|X4 Pharmaceuticals - Balans kapitallashuviga qarzlar|ACET (Adicet Bio, Inc.) - Sof aktivlarga qarzlar|Qarzning balans kapitallashuviga nisbati CELU (Celularity Inc)|Balans qiymatiga qarzlar INmune Bio Inc (INMB)|Qarzning balans qiymatiga nisbati Barinthus Bio|Qarzning balans kapitaliga nisbati Kezar Life Sciences Inc (KZR)|Balans kapitallashuviga qarzlar SAB Biotherapeutics|akaritx.com - Qarzning sof aktivlarga nisbati|Qarzning balans kapitallashuviga nisbati Enlivex Therapeutics, Ltd. (ENLV)|QTTB - Qarzning sof aktivlarga nisbati|Balans kapitallashuviga qarzlar GeoVax Labs Inc|EDSA (Edesa Biotech Corp) - Qarzning balans qiymatiga nisbati|Qarzning balans kapitallashuviga nisbati iBio, Inc. IBIO|Qarzlarning balans kapitallashuviga nisbati Carisma Tx|XTL Biopharmaceuticals Ltd. (XTLB) - Balans kapitallashuviga qarzlar|Qarzning sof aktivlarga nisbati boltbio.com (BOLT)|Balans kapitallashuviga qarzlar HCWB (HCW Biologics)|Aptevo Therapeutics, Inc. - Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati AIM ImmunoTech (AIM)|ADTX: Qarzning sof aktivlarga nisbati|GRI (GRI Bio) - Qarzning balans kapitallashuviga nisbati|XORTX Therapeutics Inc (XRTX) - Qarzning balans qiymatiga nisbati|HIND (ReShape Lifesciences) - Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar Revelation Biosciences Corp (REVB)|Indaptus Therapeutics (INDP) - Qarzning balans qiymatiga nisbati|Qarzning sof aktivlarga nisbati scinai.com (SCNI)|Balans kapitallashuviga qarzlar CALI|Affimed NV - Sof aktivlarga qarzlar|ALLK: Qarzning balans kapitallashuviga nisbati|HOOK: Qarzning balans qiymatiga nisbati|IGMS (igmbio.com) - Qarzning balans kapitallashuviga nisbati|Qarzning balans qiymatiga nisbati iteostherapeutics.com|OCEA (Ocean Biomedical) - Qarzning balans qiymatiga nisbati|Balans kapitallashuviga qarzlar TCBP